Association between Maternal Serum Uric Acid Levels with Severity and Neonatal Outcome in Preeclampsia / Eclampsia
Asian Research Journal of Gynaecology and Obstetrics,
Aims: The objective of the study is to determine the association between maternal serum uric acid levels with the severity and neonatal outcome in preeclampsia/eclampsia.
Study Design: This study was a cross-sectional study with a descriptive-analytic design.
Place and Duration of Study: Department of Obstetrics and Gynecology, Prof. Dr. R. D. Kandou General Central Hospital and affiliated hospitals in Manado, between October 2020 and February 2021.
Methodology: We included 33 normotensive pregnant women and 33 mothers diagnosed with either severe preeclampsia, HELLP syndrome, or eclampsia who delivered at Prof. Dr. R. D. Kandou General Central Hospital and affiliated hospitals in Manado. The serum uric acid of all subjects was examined using the uricase method before delivery.
Results: The mean serum uric acid level in normotensive pregnancy was 4.8 (± 0.73) mg/dL and the median value in preeclampsia / eclampsia was 9.2 (5.2-15.1) mg/dL. One-way Anova test showed a significant association between maternal serum uric acid levels with the severity of preeclampsia/eclampsia with a value of P < .001 and the degree of hypertension with a value of P < .001. At the same time, the Pearson correlation test showed a strong correlation between systolic and diastolic blood pressure with uric acid levels with rho values 0.620 (P < .001) and 0.517 (P = .002), respectively. We found no significant association between maternal serum uric acid levels and the onset of preeclampsia (P-value = .935); with gestational age at delivery (P-value = 0.431); and with the first minute APGAR score (P-value = 0.209).
Conclusion: There was a significant association between maternal serum uric acid levels and the severity of preeclampsia/ eclampsia. There was no association between maternal serum uric acid levels and neonatal outcome. We recommend investigation of maternal uric acid levels could be used to help determine the prognosis in patients with preeclampsia/eclampsia.
- uric acid
How to Cite
National population and family plannning board, ministry of health republic of Indonesia. Indonesia Demographic and Health Survey; 2012.
Kınay T, Küçük C, Kayıkçıoğlu F, Karakaya J. Severe preeclampsia versus HELLP syndrome: Maternal and perinatal outcomes at <34 and ≥34 weeks’ gestation. Balkan Med J. 2015;32(4):359–63.
Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, et al. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2018;13:291–310.
Thangaratinam S, Ismail KMK, Sharp S, Coomarasamy A, Khan KS. Accuracy of serum uric acid in predicting complications of pre-eclampsia: A systematic review. BJOG. 2006;113(4):369–78.
Kementerian kesehatan republik Indonesia. Buku pegangan sosialisasi jaminan kesehatan nasional (JKN) dalam Sistem Jaminan Sosial Nasional (SJSN). kementerian kesehatan republik Indonesia, editor. Jakarta: Kementerian Kesehatan Republik Indonesia; 2013.
Livingston JR, Payne B, Brown M, Roberts JM, Cote A-M, Magee LA, et al. Uric acid as a predictor of adverse maternal and perinatal outcomes in women hospitalized with preeclampsia. J Obstet Gynaecol Can. 2014;36(10):870–7.
Bellos I, Pergialiotis V, Loutradis D, Daskalakis G. The prognostic role of serum uric acid levels in preeclampsia: A meta-analysis. J Clin Hypertens (Greenwich). 2020;22(5):826–34.
Pecoraro V, Trenti T. Predictive value of serum uric acid levels for adverse maternal and perinatal outcomes in pregnant women with high blood pressure. A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2020;252: 447–54.
Hawkins TL-A, Roberts JM, Mangos GJ, Davis GK, Roberts LM, Brown MA. Plasma uric acid remains a marker of poor outcome in hypertensive pregnancy: a retrospective cohort study. BJOG. 2012; 119(4):484–92.
Maynard SE, Thadhani R. Pregnancy and the kidney. J Am Soc Nephrol. 2009;20(1): 14–22.
Vazquez-Rodriguez JG, Rico-Trejo EI. Role of uric acid in preeclampsia-eclampsia. Ginecol Obstet Mex. 2011; 79(5):292–7.
Lam C, Lim K-H, Kang D-H, Karumanchi SA. Uric acid and preeclampsia. Semin Nephrol. 2005;25(1):56–60.
Wantania JJ, Homenta C, Kepel BJ. Association of Heme Oxygenase-1 (HO-1) level with onset and severity in normotensive pregnancy and severe preeclampsia. Bali Med J. 2016;5(1):118.
Sánchez-Aranguren LC, Prada CE, Riaño-Medina CE, Lopez M. Endothelial dysfunction and preeclampsia: role of oxidative stress. Front Physiol. 2014;5:372.
Schoots MH, Gordijn SJ, Scherjon SA, van Goor H, Hillebrands J-L. Oxidative stress in placental pathology. Placenta. 2018;69: 153–61.
Fukushima K, Murata M, Tsukimori K, Eisuke K, Wake N. 8-Hydroxy-2-deoxyguanosine staining in placenta is associated with maternal serum uric acid levels and gestational age at diagnosis in pre-eclampsia. Am J Hypertens. 2011; 24(7):829–34.
Lee JJ, Ahn J, Hwang J, Han SW, Lee KN, Kim JB, et al. Association between uric acid and blood pressure in different age groups. Clin Hypertens. 2015;21:14.
Niraula A, Lamsal M, Majhi S, Khan SA, Basnet P. Significance of serum uric Acid in pregnancy induced hypertension. J Natl Med Assoc. 2017;109(3):198– 202.
Lanaspa MA, Andres-Hernando A, Kuwabara M. Uric acid and hypertension. Hypertens Res [Internet]. 2020;43(8): 832–4.
Paula LG, Pinheiro da Costa BE, Hentschke MR, Antonello IC, Luz JH, da Cunha Filho E V, et al. Increased proteinuria and uric acid levels are associated with eclamptic crisis. Pregnancy Hypertens. 2019;15:93–7.
Kimura C, Watanabe K, Iwasaki A, Mori T, Matsushita H, Shinohara K, et al. The severity of hypoxic changes and oxidative DNA damage in the placenta of early-onset preeclamptic women and fetal growth restriction. J Matern Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet. 2013;26(5):491–6.
Abstract View: 25 times
PDF Download: 27 times